Aller au contenu principal
Profil bibliographique

Michael S. Sharbaugh

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

69Publications signalées
1189Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Cardiac Valve Diseases and TreatmentsAtrial Fibrillation Management and OutcomesOpioid Use Disorder TreatmentCardiac pacing and defibrillation studiesSubstance Abuse Treatment and Outcomes

Les publications récentes

Accès ouvert 2025 article OpenAlex

The Use of Mental Health Services by Dually-Eligible Nursing Home Residents

Howard B. Degenholtz, Michael S. Sharbaugh, Lingshu Xue, Paige Semple et autres

Abstract Previous research on mental health service among nursing home residents has documented high rates of psychoactive medication use and increasing prevalence of people with severe mental illness (SMI). This is the first study to examine how the delivery of mental health …

us (code pays fourni par la source)

0 citations Innovation in Aging
Accès ouvert 2024 article OpenAlex

Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies

Patricia Rippetoe Freeman, Adam J. Gordon, Anna E. Austin, Julie Marie Donohue et autres

Importance: Controlled substances have regulatory requirements under the US Federal Controlled Substance Act that must be met before pharmacies can stock and dispense them. However, emerging evidence suggests there are pharmacy-level barriers in access to buprenorphine for treatment for opioid use disorder …

us (code pays fourni par la source)

0 citations Carolina Digital Repository (University of North Carolina at Chapel Hill)
Accès ouvert 2024 article OpenAlex

Barriers to Buprenorphine Dispensing by Medicaid-Participating Community Retail Pharmacies

Patricia Rippetoe Freeman, Lindsey R. Hammerslag, Katherine A. Ahrens, Michael S. Sharbaugh et autres

Importance: Controlled substances have regulatory requirements under the US Federal Controlled Substance Act that must be met before pharmacies can stock and dispense them. However, emerging evidence suggests there are pharmacy-level barriers in access to buprenorphine for treatment for opioid use disorder …

us, gb (code pays fourni par la source)

12 citations JAMA Health Forum
2023 article OpenAlex

Churn in Supplemental Nutrition Assistance Program

Liyang Xie, Jason C. O’Connor, Steven M. Albert, Tiffany L. Gary‐Webb et autres

BACKGROUND: The Supplemental Nutrition Assistance Program (SNAP) provides financial assistance to low-income individuals and families to help them purchase food. However, when participants experience short-term disenrollment from the program, known as churn, it can disrupt their health care usage patterns or result …

us (code pays fourni par la source)

3 citations Medical Care
Accès ouvert 2023 article OpenAlex

Prevalence of Testing for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Among Medicaid Enrollees Treated With Medications for Opioid Use Disorder in 11 States, 2016–2019

Katherine A. Ahrens, Michael S. Sharbaugh, Marian Jarlenski, Lu Tang et autres

BACKGROUND: Limited information exists about testing for human immunodeficiency virus (HIV), hepatitis B virus (HBV), and hepatitis C virus (HCV) among Medicaid enrollees after starting medication for opioid use disorder (MOUD), despite guidelines recommending such testing. Our objectives were to estimate testing …

us (code pays fourni par la source)

8 citations Clinical Infectious Diseases
Accès ouvert 2021 article OpenAlex

Sex differences in atrial fibrillation: patient-reported outcomes and the persistent toll on women

Raisa Lomanto Silva, Emily Guhl, Andrew D. Althouse, Brandon M. Herbert et autres

BACKGROUND: Women have worse patient-reported outcomes in atrial fibrillation (AF) than men, but the reasons remain poorly understood. We investigated how comorbid conditions, treatment, social factors, and their modification by sex would attenuate sex-specific differences in patient-reported outcomes in AF. METHODS: In …

us (code pays fourni par la source)

15 citations American Journal of Preventive Cardiology
Accès ouvert 2021 article OpenAlex

Use of Medications for Treatment of Opioid Use Disorder Among US Medicaid Enrollees in 11 States, 2014-2018

Elizabeth R. Brown, Maik Schutze, Angela Taylor, David Jorgenson et autres

Importance: There is limited information about trends in the treatment of opioid use disorder (OUD) among Medicaid enrollees. Objective: To examine the use of medications for OUD and potential indicators of quality of care in multiple states. Design, Setting, and Participants: Exploratory …

us (code pays fourni par la source)

120 citations JAMA
Accès ouvert 2021 article OpenAlex

Long term mortality and readmissions after transcatheter aortic valve replacement

Mourad Hussein Senussi, John T. Schindler, Ibrahim S. Sultan, Ahmad Masri et autres

Background: Readmissions following transcatheter aortic valve replacement (TAVR) are common but detailed analysis of cardiac and non-cardiac inpatient readmissions beyond thirty days to different levels of care are limited. Methods: Our study population was 1,037 consecutive patients who underwent TAVR between 2011–2017 …

us (code pays fourni par la source)

16 citations Cardiovascular Diagnosis and Therapy
2021 article OpenAlex

Provider and Patient-panel Characteristics Associated With Initial Adoption and Sustained Prescribing of Medication for Opioid Use Disorder

Gerald T. Cochran, Evan S. Cole, Michael S. Sharbaugh, Dylan Nagy et autres

OBJECTIVES: Limited information is available regarding provider- and patient panel-level factors associated with primary care provider (PCP) adoption/prescribing of medication for opioid use disorder (MOUD). METHODS: We assessed a retrospective cohort from 2015 to 2018 within the Pennsylvania Medicaid Program. Participants included …

us, gb (code pays fourni par la source)

2 citations Journal of Addiction Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.